Novo Nordisk is a world-leading healthcare company founded in 1923 and headquartered in Copenhagen, Denmark with more than 55,000 employees worldwide. Our purpose is to drive change to defeat serious chronic diseases such as diabetes and obesity.

We are expanding our global presence with the establishment of a large state-of-the-art research and development hub encompassing functions from research to clinic in greater Boston.  Here, we will pioneer breakthrough discoveries with seamless collaboration and connect our expertise to the leading life science ecosystem.  The hub will be home to multidisciplinary teams, comprised by some of the brightest scientists, united by the singular goal of developing innovative treatments that revolutionize the field of life science.

As part of the hub, we are building a vibrant scientific department bringing forward the next generation of drug delivery systems to unlock the therapeutic potential of new modalities across a range of serious chronic diseases.  We will explore and advance novel drug delivery technologies such as oral, subcutaneous and alternative routes to address unmet needs in close collaboration with colleagues in greater Boston and Denmark.

We are a part of Research & Early Development (R&ED) at Novo Nordisk. We work in multidisciplinary teams with our R&ED colleagues to drive the idea exploration and early drug discovery process.  We engage in external collaborations e.g, with leading universities and biotech companies to access the latest research and technology innovation. 

You have documented experience in advanced drug delivery (oral, subcutaneous, alternative routes) and pharmaceutical sciences in general.  Hands-on experience and knowledge about formulating new modalities, characterizing delivery systems and the physiology of biological barriers is desired.  Furthermore, you must have a demonstrated evidence (publication, patents, etc.) of innovation within novel drug delivery systems.

You will be part of building a team based on collaboration and cutting-edge science with leading experts where innovation is at the core. You will bring your own ideas to the table and work closely with colleagues and external partners. ​

The team in Boston will help realize our ambition of pioneering the next generation of drug delivery.

Stephen is a Scientific Vice President at Novo Nordisk and is heading up the advanced drug delivery research in greater Boston. Listen to him talk about the team vision and his role as a leader.